| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.95B | 23.54B | 34.60B | 36.98B | 34.87B | 29.61B |
| Gross Profit | 14.24B | 12.07B | 17.66B | 19.50B | 17.90B | 13.11B |
| EBITDA | 2.60B | -1.96B | 5.21B | 6.69B | 5.72B | 1.62B |
| Net Income | 886.00M | -2.08B | 2.57B | 3.64B | 5.30B | -1.78B |
Balance Sheet | ||||||
| Total Assets | 49.72B | 47.69B | 54.93B | 52.55B | 51.16B | 45.40B |
| Cash, Cash Equivalents and Short-Term Investments | 16.88B | 16.21B | 21.65B | 20.13B | 20.40B | 19.48B |
| Total Debt | 914.00M | 0.00 | 3.00M | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.92B | 4.75B | 8.15B | 9.61B | 11.37B | 8.78B |
| Stockholders Equity | 43.80B | 42.94B | 46.78B | 42.94B | 39.79B | 36.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.20B | 3.36B | 1.54B | 4.40B | 982.00M |
| Operating Cash Flow | 0.00 | -4.89B | 4.61B | 3.73B | 5.51B | 3.07B |
| Investing Cash Flow | 0.00 | 322.00M | -2.02B | -2.47B | -911.00M | -1.36B |
| Financing Cash Flow | 0.00 | -1.16B | -1.17B | -1.13B | -3.47B | -1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥19.00B | 6.27 | ― | 1.27% | 15.12% | 23.65% | |
66 Neutral | ¥20.80B | 7.10 | ― | 0.76% | 18.01% | -2.49% | |
64 Neutral | ¥380.07B | 17.60 | 10.65% | 1.64% | 5.49% | 3.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥14.01B | 11.95 | ― | 0.55% | 16.33% | -38.51% | |
55 Neutral | ¥6.39B | 15.09 | ― | 2.41% | 0.03% | -0.59% | |
50 Neutral | ¥21.17B | -9.85 | ― | 5.22% | -31.95% | -181.05% |